Patients treated by psychiatrists (OR, 21.1; 95% CI, 13.2-33.7) and neurologists (19.7; 12.3-31.5) had higher odds of receiving modafinil relative to primary care physicians and other specialists, whereas patients seeing pulmonologists and otolaryngologists were not statistically more likely to be receiving modafinil (eTable 2).